THIRD READING 

Bill No: ACR 33

Author: Gloria (D), et al.

Introduced: 2/20/19

Vote: 21

ASSEMBLY FLOOR: Read and adopted, 3/7/19

SUBJECT: Lymphedema Awareness Day

SOURCE: Author

DIGEST:

This resolution declares March 6, 2019, as Lymphedema Awareness Day in California.

ANALYSIS: This resolution makes the following legislative findings:

1. Lymphedema (LE) is a serious chronic disease that plagues nearly 10 million Americans who are either born with the condition or who develop it as a result of trauma, surgical insult, radiation therapy, or a combination of these factors.
2. LE is a disease that occurs when the body’s natural lymphatic drainage system is damaged or blocked or does not develop properly and the lymphatic fluid within a given area, such as the arm, leg, torso, head, or neck, is unable to drain properly. This results in extreme swelling that can cause pain and significantly impairs mobility, function, and the quality of life for the affected person.
3. Underdiagnosing and undertreating LE patients cost health care providers and health care coverage policies or plans, including the federal Medicare Program, untold millions of dollars every year because, if LE is left untreated, the potential for infection is greatly increased, possibly spreading in the course of a few hours, and requiring immediate treatment on an emergency basis.
4. Without professional treatment and self‑care, the accumulation of lymphatic fluid results in the gross distention of the lymph-filled body part and chronic infections that can become life‑threatening without prompt treatment.
5. LE often leaves its victims disfigured, as well as physically and emotionally disabled.
6. Many LE patients are breast cancer survivors who have undergone surgery or lymph node removal, often in combination with subsequent radiation therapy. However, similar treatments for colon cancer, melanoma, and uterine, ovarian, and cervical cancer can also cause LE.
7. Persons at risk for LE must apply a regimen of self-care to prevent or delay the onset of symptoms that is nearly as rigorous as self-care requirements for patients already afflicted with LE.

This resolution declares March 6, 2019, as Lymphedema Awareness Day in California.

Related/Prior Legislation

SCR 77 (Alquist, Resolution Chapter 42, Statutes of 2006) declared March 6, 2006, to be Lymphedema Awareness Day.

FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No

SUPPORT: (Verified 3/18/19)

None received

OPPOSITION: (Verified 3/18/19)

None received

Prepared by: Karen Chow / SFA / (916) 651-1520

3/20/19 14:41:02

**** END ****

ASSEMBLY THIRD READING

ATR Bill Id:ACR 33

Author:(Gloria)

As Introduced Ver:February 20, 2019

Majority vote

SUMMARY:

Declares March 6, 2019, as Lymphedema Awareness Day in California. Specifically, this resolution makes the following legislative findings:

1. Lymphedema (LE) is a serious chronic disease that plagues nearly 10 million Americans who are either born with the condition or who develop it as a result of trauma, surgical insult, radiation therapy, or a combination of these factors.
2. LE is a disease that occurs when the body's natural lymphatic drainage system is damaged or blocked or does not develop properly and the lymphatic fluid within a given area, such as the arm, leg, torso, head, or neck, is unable to drain properly. This results in extreme swelling that can cause pain and significantly impairs mobility, function, and the quality of life for the affected person.
3. Worldwide, the World Health Organization estimates that over 150 million people have secondary LE and an additional 120 million people are infected with lymphatic filariasis, which leads to lymphedema.
4. Underdiagnosing and undertreating LE patients cost health care providers and health care coverage policies or plans, including the federal Medicare Program, untold millions of dollars every year because, if LE is left untreated, the potential for infection is greatly increased, possibly spreading in the course of a few hours, and requiring immediate treatment on an emergency basis.
5. Several thousand Californians will be put at risk or will develop LE each year as a consequence of cancer treatment, surgical insult, or physical trauma.
6. Timely diagnosis and treatment are often not available to patients, particularly those in rural areas, making LE more difficult to manage with more negative health consequences due to delays in diagnosing and treating the condition.
7. It is important to recognize the tireless advocates and health care providers who spend so much of their time and resources battling this painful and destructive condition that affects so many members of the community.
8. World Lymphedema Day is recognized on March 6 of each year.

Major Provisions

None

COMMENTS:

None

According to the Author:

None

Arguments in Support:

None

Arguments in Opposition:

None

FISCAL COMMENTS:

No fiscal impact

VOTES:

ASM RULES: 11-0-1

YES: Cooley, Carrillo, Flora, Grayson, Kamlager-Dove, Maienschein, Mathis, Quirk-Silva, Ramos, Robert Rivas, Wicks

ABS, ABST OR NV: Cunningham

UPDATED:

VERSION: February 20, 2019

CONSULTANT: Nicole Willis / RLS. / (916) 319-2800 FN: 0000040

Date of Hearing: February 28, 2019

ASSEMBLY COMMITTEE ON RULES

Ken Cooley, Chair

ABPCA Bill Id:ACR 33 (

Author:Gloria) – As Introduced Ver:February 20, 2019

SUBJECT: Lymphedema Awareness Day.

SUMMARY: Declares March 6, 2019, as Lymphedema Awareness Day in California. Specifically, this resolution makes the following legislative findings:

1. Lymphedema (LE) is a serious chronic disease that plagues nearly 10 million Americans who are either born with the condition or who develop it as a result of trauma, surgical insult, radiation therapy, or a combination of these factors.
2. LE is a disease that occurs when the body’s natural lymphatic drainage system is damaged or blocked or does not develop properly and the lymphatic fluid within a given area, such as the arm, leg, torso, head, or neck, is unable to drain properly. This results in extreme swelling that can cause pain and significantly impairs mobility, function, and the quality of life for the affected person.
3. Worldwide, the World Health Organization estimates that over 150 million people have secondary LE and an additional 120 million people are infected with lymphatic filariasis, which leads to lymphedema.
4. Underdiagnosing and undertreating LE patients cost health care providers and health care coverage policies or plans, including the federal Medicare Program, untold millions of dollars every year because, if LE is left untreated, the potential for infection is greatly increased, possibly spreading in the course of a few hours, and requiring immediate treatment on an emergency basis.
5. Several thousand Californians will be put at risk or will develop LE each year as a consequence of cancer treatment, surgical insult, or physical trauma.
6. Timely diagnosis and treatment are often not available to patients, particularly those in rural areas, making LE more difficult to manage with more negative health consequences due to delays in diagnosing and treating the condition.
7. It is important to recognize the tireless advocates and health care providers who spend so much of their time and resources battling this painful and destructive condition that affects so many members of the community.
8. World Lymphedema Day is recognized on March 6 of each year.

FISCAL EFFECT: None

REGISTERED SUPPORT / OPPOSITION:

Support

None on file

Opposition

None on file

Analysis Prepared by: Nicole Willis / RLS. / (916) 319-2800